DarioHealth Corp. (DRIO) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
DarioHealth Corp. (DRIO) Bundle
Enhance your investment strategies with the DarioHealth Corp. (DRIO) DCF Calculator! Utilize real DarioHealth financial data, adjust growth predictions and expenses, and instantly observe how these changes influence the intrinsic value of DarioHealth Corp. (DRIO).
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.6 | 7.6 | 20.5 | 27.7 | 20.4 | 25.9 | 32.9 | 41.8 | 53.2 | 67.7 |
Revenue Growth, % | 0 | 0.2249 | 170.76 | 34.82 | -26.41 | 27.16 | 27.16 | 27.16 | 27.16 | 27.16 |
EBITDA | -17.5 | -29.7 | -73.1 | -56.8 | -54.4 | -25.9 | -32.9 | -41.8 | -53.2 | -67.7 |
EBITDA, % | -231.8 | -392.2 | -356.44 | -205.42 | -267.19 | -100 | -100 | -100 | -100 | -100 |
Depreciation | .6 | .5 | 3.5 | 3.8 | 5.0 | 3.6 | 4.5 | 5.8 | 7.3 | 9.3 |
Depreciation, % | 7.29 | 6.03 | 17.2 | 13.73 | 24.49 | 13.75 | 13.75 | 13.75 | 13.75 | 13.75 |
EBIT | -18.1 | -30.2 | -76.6 | -60.6 | -59.4 | -25.9 | -32.9 | -41.8 | -53.2 | -67.7 |
EBIT, % | -239.09 | -398.23 | -373.64 | -219.15 | -291.68 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 20.4 | 28.6 | 35.8 | 49.4 | 36.8 | 25.9 | 32.9 | 41.8 | 53.2 | 67.7 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .7 | 1.7 | 1.8 | 6.4 | 3.4 | 4.2 | 5.3 | 6.7 | 8.6 | 10.9 |
Account Receivables, % | 9.42 | 22.49 | 8.71 | 23.2 | 16.73 | 16.11 | 16.11 | 16.11 | 16.11 | 16.11 |
Inventories | 1.4 | 2.3 | 6.2 | 8.0 | 5.1 | 6.9 | 8.8 | 11.1 | 14.2 | 18.0 |
Inventories, % | 18.71 | 30.27 | 30.36 | 28.77 | 24.87 | 26.59 | 26.59 | 26.59 | 26.59 | 26.59 |
Accounts Payable | 1.7 | 2.5 | 5.1 | 2.3 | 1.1 | 4.8 | 6.2 | 7.8 | 10.0 | 12.7 |
Accounts Payable, % | 21.91 | 32.73 | 24.91 | 8.4 | 5.56 | 18.7 | 18.7 | 18.7 | 18.7 | 18.7 |
Capital Expenditure | -.1 | -.1 | -.3 | -.6 | -.6 | -.5 | -.6 | -.8 | -1.0 | -1.2 |
Capital Expenditure, % | -1.3 | -1.56 | -1.27 | -2.07 | -2.87 | -1.81 | -1.81 | -1.81 | -1.81 | -1.81 |
Tax Rate, % | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 |
EBITAT | -18.1 | -29.7 | -76.7 | -60.6 | -59.4 | -25.8 | -32.8 | -41.7 | -53.0 | -67.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -18.1 | -30.4 | -74.8 | -66.5 | -50.3 | -21.6 | -30.6 | -38.9 | -49.4 | -62.8 |
WACC, % | 7.3 | 7.26 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 |
PV UFCF | ||||||||||
SUM PV UFCF | -159.6 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -64 | |||||||||
Terminal Value | -1,210 | |||||||||
Present Terminal Value | -851 | |||||||||
Enterprise Value | -1,011 | |||||||||
Net Debt | -7 | |||||||||
Equity Value | -1,003 | |||||||||
Diluted Shares Outstanding, MM | 28 | |||||||||
Equity Value Per Share | -35.37 |
What You Will Get
- Real DarioHealth Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on DarioHealth’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Historical Data: DarioHealth Corp.'s (DRIO) past financial statements and projected forecasts.
- Customizable Parameters: Adjust inputs like WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Instantly view DarioHealth Corp.'s (DRIO) intrinsic value as it updates live.
- Intuitive Visual Representations: Dashboard visuals showcase valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Download: Access the ready-to-use Excel file with DarioHealth Corp.'s (DRIO) financial data.
- Customize: Adjust forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations update in real-time.
- Test Scenarios: Create multiple projections and compare outcomes instantly.
- Make Decisions: Use the valuation results to guide your investment strategy.
Why Choose This Calculator for DarioHealth Corp. (DRIO)?
- Accurate Data: Utilizes the latest DarioHealth financials for dependable valuation insights.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Built-in calculations save you the hassle of starting from scratch.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions make it accessible for all users.
Who Should Use DarioHealth Corp. (DRIO)?
- Healthcare Investors: Develop comprehensive and accurate valuation models for evaluating investment opportunities.
- Corporate Strategy Teams: Assess valuation scenarios to inform business decisions and growth strategies.
- Financial Consultants: Deliver precise valuation insights for clients interested in DarioHealth Corp. (DRIO).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Health Tech Enthusiasts: Gain insights into the market valuation of innovative health technology companies like DarioHealth Corp. (DRIO).
What the Template Contains
- Pre-Filled DCF Model: DarioHealth Corp.'s (DRIO) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital tailored to DarioHealth.
- Financial Ratios: Assess DarioHealth's profitability, leverage, and efficiency metrics.
- Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to suit your analysis.
- Financial Statements: Comprehensive annual and quarterly reports for in-depth evaluation.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and results for DarioHealth Corp.